3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
2
CNS
2
Other solid neoplasm
1
Myeloid
1
Genitourinary
1
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
10
Pancreatic Neoplasms
9
Neoplasm Metastasis
5
Breast Neoplasms
5
Melanoma
4
Colorectal Neoplasms
4
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Lymphoma
3
Lung Neoplasms
3
Liver Neoplasms
3
Carcinoma, Renal Cell
3
Wilms Tumor
2
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Neuroblastoma
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasms
2
Kidney Neoplasms
2
Astrocytoma
2
Adenomatous Polyposis Coli
2
Thyroid Neoplasms
1
Thrombocytosis
1
Somatostatinoma
1
Sarcoma, Clear Cell
1
Retinoblastoma
1
Interventions
Magnetic Resonance Spectroscopy
7
X-Rays
6
Specimen Handling
6
Phantoms, Imaging
6
Nuclear Medicine Department, Hospital
5
Carboplatin
4
Biopsy
4
Thiotepa
3
Temozolomide
3
Melphalan
3
Ifosfamide
3
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
Etoposide
3
Busulfan
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
etoposide phosphate
2
erdafitinib
2
ensartinib
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Mesna
2
LY3023414
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Medulloblastoma
×
Sirolimus
×
Gastrointestinal
×
Clear all
NCT01331135
2020-05-29
Aflac ST0901
Emory University
Phase 1
Completed
18 enrolled